RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
86 hedge funds and large institutions have $462M invested in Rubius Therapeutics, Inc in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
+10
Holders Change %
+13.16%
% of All Funds
1.77%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
23
Increased
32
Reduced
18
Closed
13
Calls
$268K
Puts
–
Net Calls
+$268K
Net Calls Change
+$267K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$12.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$62.4M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$2.22M |
| 4 |
BlackRock
New York
|
$20M |
| 5 |
MA
MYDA Advisors
Woodmere,
New York
|
$1.76M |
